The Food and Drug Administration (FDA) has granted emergency authorization for select COVID-19 vaccines. Pfizer’s vaccine for children aged six months to five years old and Moderna’s vaccine for children aged six months to six years old have been approved. Shortly after the FDA’s authorization, the Center for Disease Control and Prevention (CDC) accepted the recommendations for the vaccination of infants and young children.
The Moderna vaccination plan calls for a series of two inoculations, each at a quarter of an adult dose. The second vaccine is recommended to be spaced three weeks after the initial. Meanwhile, the Pfizer vaccination plan entails a series of three inoculations. The second vaccine is recommended to be given three weeks after the first with the final vaccine being given eight weeks after the second.
Despite the lower dosages than the adult versions, research has confirmed similar autobody immune responses. Though the study was relatively small, researchers believe these vaccines to tentatively be as effective as a flu shot in preventing infection.
The vaccines became available on June 21. It is important to know when receiving other recommended and routine vaccinations, infants and children can simultaneously receive either of the approved COVID-19 vaccines.
Natural Immunity vs Vaccination
While approximately three out of four children have already contracted COVID-19, physicians still recommend children get vaccinated. Children who contracted COVID-19 should still seek out vaccination. Natural immunity offers some unique protections; however, the best way to protect against future infection is to become fully vaccinated.
As more information is released, Creative Benefits will provide updates.